Adherence is associated with a favorable outcome after lung transplantation
Open accessThe DOI matches its Crossref record; 53 of the 56 references it cites were found in a registry or an index; 9 of the 52 sources its claims cite were checked for support.
Abstract
Patients with good adherence within the first three years showed better 5-year allograft and patient survival and lower prevalence of chronic allograft dysfunction after 5 years compared to patients with suboptimal adherence.
Overview
CoChat Summary
TL;DR
In this single-center retrospective cohort of 427 adult lung transplant recipients, a multidimensional adherence score assessed during routine follow-up was associated with better 5-year allograft and patient survival. Patients with good adherence in the first 3 years had higher 5-year allograft survival (74% vs. 60%), higher patient survival (79% vs. 64%), and lower CLAD prevalence (33% vs. 45%).
Key findings
- Median adherence in the first 3 years after lung transplantation was 86% (IQR 79–90%) across 6,623 scored visits.
- Using the 86% median cutoff, patients with good adherence had better 5-year allograft survival (74% vs. 60%, p = 0.003), patient survival (79% vs. 64%, p < 0.001), and lower CLAD prevalence (33% vs. 45%, p = 0.011).
- Patients with suboptimal adherence had more and longer hospitalizations; quality of life tended to improve over time in the good-adherence group and decline in the low-adherence group.
- In multivariate logistic regression, only the subscore “home spirometry” showed a significant association with patient survival, with an odds ratio of 4.2 (p = 0.008) for negative outcome.
Methods
- Design: Single-center retrospective cohort study at Hannover Medical School; adherence was assessed prospectively at every outpatient visit using a five-item, healthcare-worker-rated Likert score (0–100%).
- Sample/data: Included 427 adult patients with first lung transplantation between January 1, 2010 and December 31, 2013 who entered outpatient follow-up; median follow-up was 5.9 years (IQR 4.1–7.3).
- Analysis: ROC curves, median-based cutoff selection, chi-square/Fisher tests, Mann-Whitney U/t tests, Kaplan-Meier survival analyses with log-rank tests, and stratified analyses by diagnosis; multivariate logistic regression was used for subscores.
Limitations
- The paper states it was a single-center retrospective study, and that interventions to improve adherence were performed and may have interfered.
- The authors note that not all factors lowering the score reflected non-adherence; drug interactions, malabsorption, medical complications, or wasting/underweight could also affect scores.
- The adherence score was not validated, and inter-observer variability was not tested; the text says this was partly because the score was completed by coordinators, checked by physicians, and discussed in team meetings.
- Evident from the text: the study is observational, so the reported associations cannot establish causality.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
7 Valid · 2 Not valid · 25 Not checked · 51 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“High variability was associated with unfavorable allograft outcome in solid organ transplant recipients, including patients after lung transplantation[10,37–39].”
§ Adherence is associated with a favorable outcome after lung transplantation > Discussion
What the sources say
- Not checked — no full text of the sourcecites [10] M Hsiau, 2011, Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation, Transplantation source
- Not checked — no full text of the sourcecites [37] MS Flippin, 2000, Increased morbidity and high variability of cyclosporine levels in pediatric heart transplant recipients, J Heart Lung Transplant source
- Partly supportedcites [38] M Kreuzer, 2015, Transitional Care and Adherence of Adolescents and Young Adults After Kidney Transplantation in Germany and Austria: A Binational Observatory Census Within the TRANSNephro Trial, Medicine (Baltimore) sourceExperimental — accuracy not yet measured
The Discussion (Graft Function and Medication Adherence in Transition; page not provided) reports that previous studies linked high tacrolimus blood-level variability to late rejection and graft failure in children with kidney and other solid-organ transplants. It does not identify lung transplant recipients, and the authors found no statistically significant predictive value for rejection or graft loss in their own kidney-transplant cohort. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [39] HM Gallagher, 2015, Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival, J Heart Lung Transplant source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Demographics did not significantly differ between the two adherence groups (Table 2).”
§ Adherence is associated with a favorable outcome after lung transplantation > Results > Disease specific differences
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Patients with pulmonary fibrosis used home spirometry more frequently than patients with CF.”
§ Adherence is associated with a favorable outcome after lung transplantation > Results > Disease specific differences
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We did the analysis both for the whole cohort and after exclusion of heart lung transplant patients. The latter did not change the results for the discriminating median (86.2%) and for the Kaplan-Meier estimates, although heart lung transplant patients were mostly in the suboptimal adherence group (12/13).”
§ Adherence is associated with a favorable outcome after lung transplantation > Results > Clinical outcome
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mean adherence scores declined with time after LTx, suggesting that patients tend to be more adherent in the first months after transplantation and to be more careless in the following years.”
§ Adherence is associated with a favorable outcome after lung transplantation > Discussion
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
14 more claims
Create a free account to see all 85 claims and to verify the 11 references still open.
- Probably not a substantial claim. 52
- It may state two separate claims as one. 30
Citations
Cites
Adherence to Long-Term Therapies: Evidence for Action
De Geest, S., & Sabaté, E. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,272
Sellarés, J., de Freitas, D. G., Mengel, M., Reeve, J., Einecke, G., Sis, B., Hidalgo, L. G., Famulski, K., Matas, A., & Halloran, P. F. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03840.x · Cited by 1,590 · cited 1×
“Few publications have identified an association of non-adherence in the patient’s record to impaired graft survival[3,5].”
BackgroundHurst, N. P., Kind, P., Ruta, D., Hunter, M., & Stubbings, A. (1997) · Rheumatology · doi:10.1093/rheumatology/36.5.551 · Cited by 826 · cited 1×
“Patients rated quality of life on a visual analogue scale (EQ5D[15]) on every visit.”
Dobbels, F., Vanhaecke, J., Dupont, L., Nevens, F., Verleden, G., Pirenne, J., & De Geest, S. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a440ae · Cited by 272 · cited 1×
“Pre-transplantation non-adherence predicted post-transplantation nonadherence, but the correlation between post-transplantation non-adherence and outcome was not analyzed[32,33].”
BackgroundMeta-Analysis of Medical Regimen Adherence Outcomes in Pediatric Solid Organ Transplantation
Dew, M. A., Dabbs, A. D., Myaskovsky, L., Shyu, S., Shellmer, D. A., DiMartini, A. F., Steel, J., Unruh, M., Switzer, G. E., Shapiro, R., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181b2a0e0 · Cited by 264
Measuring, Analyzing, and Managing Drug Adherence in Resistant Hypertension
Burnier, M., Wuerzner, G., Struijker-Boudier, H., & Urquhart, J. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.00687 · Cited by 229 · cited 2×
“This finding is in line with the literature on medication adherence in general[31] and in LTx patients[49] and was also demonstrated for self-reported adherence in patients from our center[27].”
BackgroundResultDobbels, F., Berben, L., De Geest, S., Drent, G., Lennerling, A., Whittaker, C., & Kugler, C. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e346cd · Cited by 220
Takemoto, S. K., Pinsky, B. W., Schnitzler, M. A., Lentine, K. L., Willoughby, L. M., Burroughs, T. E., & Bunnapradist, S. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01966.x · Cited by 202 · cited 1×
“Other groups used the discrepancy between immunosuppressant dosages and prescription refills or data from health insurances for the assessment of adherence[35,36].”
MethodSchäfer-Keller, P., Steiger, J., Bock, A., Denhaerynck, K., & De Geest, S. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02127.x · Cited by 198
Denhaerynck, K., Steiger, J., Bock, A., Schäfer-Keller, P., Köfer, S., Thannberger, N., & De Geest, S. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01611.x · Cited by 184 · cited 12×
“Most publications focus on adherence to immunosuppressants, assessed with electronic medication event monitoring systems (MEMS), self-reports, or surrogate parameters like therapeutic drug monitoring[9,10].”
BackgroundInfluentialShi, L., Liu, J., Fonseca, V., Walker, P., Kalsekar, A., & Pawaskar, M. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-99 · Cited by 177
Langer, D., Burtin, C., Schepers, L., Ivanova, A., Verleden, G., Decramer, M., Troosters, T., & Gosselink, R. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04000.x · Cited by 170 · cited 1×
“Regular physical exercise has a positive effect on quality of life, exercise capacity and posttransplant hypertension in LTx patients[46,47] and we encourage all our patients to regularly perform exercises by themselves or to take part in medical training programs, depending on their capabilities.”
BackgroundFeasibility of an Ingestible Sensor-Based System for Monitoring Adherence to Tuberculosis Therapy
Belknap, R., Weis, S., Brookens, A., Au-Yeung, K. Y., Moon, G., DiCarlo, L., & Reves, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053373 · Cited by 160 · cited 1×
“Ingestible sensors combined with or embedded in tablets may accurately determine taking adherence[23,24].”
BackgroundMartín‐Gandul, C., Mueller, N. J., Pascual, M. A., & Manuel, O. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13486 · Cited by 160 · cited 1×
“Long-term allograft survival is limited by the development of chronic lung allograft dysfunction (CLAD), malignancy, infections, and comorbidities[1,2].”
BackgroundPilot study of a Web-based compliance monitoring device for patients with congestive heart failure
Artinian, N. T., Harden, J. K., Kronenberg, M. W., Vander Wal, J. S., Daher, E., Stephens, Q., & Bazzi, R. I. (2003) · Heart & Lung · doi:10.1016/s0147-9563(03)00026-8 · Cited by 139 · cited 1×
“Advanced electronic systems integrate interventions to improve adherence, such as alarms as a reminder to take the medication[22].”
BackgroundBody composition and mortality after adult lung transplantation in the United States
Singer, J. P., Peterson, E. R., Snyder, M. E., Katz, P. P., Golden, J. A., D’Ovidio, F., Bacchetta, M., Sonett, J. R., Kukreja, J., Shah, L., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201405-0973oc · Cited by 133 · cited 1×
“An impact of both underweight and obesity on mortality has been reported for LTx recipients[45].”
BackgroundDe Geest, S., Burkhalter, H., Bogert, L., Berben, L., Glass, T. R., Denhaerynck, K., & the Psychosocial Interest Group and Swiss Transplant Cohort Study (2014) · Transplant International · doi:10.1111/tri.12312 · Cited by 132 · cited 1×
“Pre-transplantation non-adherence predicted post-transplantation nonadherence, but the correlation between post-transplantation non-adherence and outcome was not analyzed[32,33].”
BackgroundAdherence to the Medical Regimen During the First Two Years After Lung Transplantation
Dew, M. A., DiMartini, A. F., De Vito Dabbs, A., Zomak, R., De Geest, S., Dobbels, F., Myaskovsky, L., Switzer, G. E., Unruh, M., Steel, J. L., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e318160135f · Cited by 124
Effect of late medication non-compliance on outcome after heart transplantation: A 5-year follow-up
Dobbels, F., De Geest, S., van Cleemput, J., Droogne, W., & Vanhaecke, J. (2004) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2003.09.016 · Cited by 122 · cited 1×
“For heart transplant patients, non-adherence assessed by MEMS was associated with unfavorable outcomes[21].”
BackgroundHsiau, M., Fernandez, H. E., Gjertson, D., Ettenger, R. B., & Tsai, E. W. (2011) · Transplantation · doi:10.1097/tp.0b013e31822dc34f · Cited by 121
Impact of medication non-adherence on survival after pediatric heart transplantation in the USA
Oliva, M., Singh, T. P., Gauvreau, K., VanderPluym, C. J., Bastardi, H. J., & Almond, C. S. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.03.008 · Cited by 120
Becker, S., Kribben, A., Meister, S., Diamantidis, C. J., Unger, N., & Mitchell, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078547 · Cited by 113 · cited 1×
“We feel that it is crucial to recognize a decline in adherence in time in order to initiate measures to improve adherence, such as intensification of education[17] or implementation of applications for mobile devices[17,51,52].”
BackgroundClifford, S., Perez-Nieves, M., Skalicky, A. M., Reaney, M., & Coyne, K. S. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.884491 · Cited by 99
Current views on chronic rejection after lung transplantation
Verleden, G. M., Vos, R., Vanaudenaerde, B., Dupont, L., Yserbyt, J., Van Raemdonck, D., & Verleden, S. (2015) · Transplant International · doi:10.1111/tri.12579 · Cited by 92 · cited 1×
“Restrictive allograft syndrome (RAS) was defined as an additional decline in total lung capacity to<80% of baseline or significant opacities on thoracic CT scan after exclusion of other causes[13,14].”
BackgroundNonadherent Behaviors After Solid Organ Transplantation
Germani, G., Lazzaro, S., Gnoato, F., Senzolo, M., Borella, V., Rupolo, G., Cillo, U., Rigotti, P., Feltrin, G., Loy, M., et al. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.09.103 · Cited by 91
De Bleser, L., Dobbels, F., Berben, L., Vanhaecke, J., Verleden, G., Nevens, F., & De Geest, S. (2011) · Transplant International · doi:10.1111/j.1432-2277.2011.01296.x · Cited by 89
A wearable sensor system for medication adherence prediction
Kalantarian, H., Motamed, B., Alshurafa, N., & Sarrafzadeh, M. (2016) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2016.03.004 · Cited by 86 · cited 1×
“Recently, a necklace has been described that detects swallowing of tablets based on neck movements[25].”
BackgroundPabst, S., Bertram, A., Zimmermann, T., Schiffer, M., & de Zwaan, M. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.09.001 · Cited by 72 · cited 2×
“In our transplant center, LTx and kidney transplant patients judged their adherence as poorer than health care professionals’ estimates, with our adherence score being an independent predictor of self-reported non-adherence in LTx patients[8,27].”
BackgroundSelf-citationBjortuft, O., Johansen, B., Boe, J., Foerster, A., Holter, E., & Geiran, O. (1993) · European Respiratory Journal · doi:10.1183/09031936.93.06050705 · Cited by 70 · cited 1×
“All patients were instructed in the correct daily use of the home spirometry device in order to detect changes in FEV1 and allograft dysfunction early[16].”
MethodDuerinckx, N., Burkhalter, H., Engberg, S. J., Kirsch, M., Klem, M.-L., Sereika, S. M., De Simone, P., De Geest, S., & Dobbels, F. (2016) · Transplantation · doi:10.1097/tp.0000000000001335 · Cited by 68 · cited 1×
“However, especially smoking has been associated with mortality, malignancies and cardiovascular disease after solid organ transplantation[48] and can objectively assessed by health care workers by monitoring blood or urine levels of cotinine.”
BackgroundShellmer, D. A., Dew, M. A., Mazariegos, G. V., & Dabbs, A. D. (2016) · Pediatric Transplantation · doi:10.1111/petr.12639 · Cited by 66 · cited 1×
“We feel that it is crucial to recognize a decline in adherence in time in order to initiate measures to improve adherence, such as intensification of education[17] or implementation of applications for mobile devices[17,51,52].”
BackgroundThe challenges of using medication event monitoring technology with pediatric transplant patients
Shellmer, D. A., & Zelikovsky, N. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00681.x · Cited by 65 · cited 1×
“MEMS[18,19] are considered the gold standard to assess adherence to immunosuppressants in clinical studies[20].”
BackgroundFactors Associated with Adherence to Treatment Regimens after Lung Transplantation
Teichman, B., Burker, E. J., Weiner, M., & Egan, T. M. (2000) · Progress in Transplantation · doi:10.1177/152692480001000208 · Cited by 65 · cited 1×
“This finding is in line with the literature on medication adherence in general[31] and in LTx patients[49] and was also demonstrated for self-reported adherence in patients from our center[27].”
ResultSuhling, H., Rademacher, J., Zinowsky, I., Fuge, J., Greer, M., Warnecke, G., Smits, J. M., Bertram, A., Haverich, A., Welte, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090828 · Cited by 54
Self-citationGallagher, H. M., Sarwar, G., Tse, T., Sladden, T. M., Hii, E., Yerkovich, S. T., Hopkins, P. M., & Chambers, D. C. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.05.028 · Cited by 51 · cited 1×
“Gallagher et al.[39] could demonstrate that higher mean tacrolimus trough levels 6–12 months after LTx were associated with reduced risk of CLAD but also that higher standard deviations of tacrolimus levels correlated with the incidence of CLAD and death.”
BackgroundLevy, L., Huszti, E., Tikkanen, J., Ghany, R., Klement, W., Ahmed, M., Husain, S., Fiset, P. O., Hwang, D., Keshavjee, S., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15561 · Cited by 51 · cited 1×
“It was demonstrated that low grade A1 rejection was not associated with CLAD[34].”
BackgroundKugler, C., Fuehner, T., Dierich, M., DeWall, C., Haverich, A., Simon, A., Welte, T., & Gottlieb, J. (2009) · Transplantation · doi:10.1097/tp.0b013e3181aad129 · Cited by 50
Self-citationGallagher, B. D., Muntner, P., Moise, N., Lin, J. J., & Kronish, I. M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000503 · Cited by 50 · cited 1×
“Patients tend to overestimate their adherence in self-reports with a self-reported adherence rate of 75–90%, while electronic measurements indicated adherence in less than 60% of patients[30].”
BackgroundIhle, F., Neurohr, C., Huppmann, P., Zimmermann, G., Leuchte, H., Baumgartner, R., Kenn, K., Sczepanski, B., Hatz, R., Czerner, S., et al. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.02.006 · Cited by 50 · cited 1×
“Regular physical exercise has a positive effect on quality of life, exercise capacity and posttransplant hypertension in LTx patients[46,47] and we encourage all our patients to regularly perform exercises by themselves or to take part in medical training programs, depending on their capabilities.”
BackgroundKreuzer, M., Prüfe, J., Oldhafer, M., Bethe, D., Dierks, M.-L., Müther, S., Thumfart, J., Hoppe, B., Büscher, A., Rascher, W., et al. (2015) · Medicine · doi:10.1097/md.0000000000002196 · Cited by 48
Phenotyping Chronic Lung Allograft Dysfunction Using Body Plethysmography and Computed Tomography
Suhling, H., Dettmer, S., Greer, M., Fuehner, T., Avsar, M., Haverich, A., Welte, T., & Gottlieb, J. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13876 · Cited by 45 · cited 1×
“Restrictive allograft syndrome (RAS) was defined as an additional decline in total lung capacity to<80% of baseline or significant opacities on thoracic CT scan after exclusion of other causes[13,14].”
BackgroundSelf-citationVanhoof, J. M. M., Vandenberghe, B., Geerts, D., Philippaerts, P., Mazière, P. D., Dabbs, A. D., Geest, S. D., & Dobbels, F. (2018) · Clinical Transplantation · doi:10.1111/ctr.13314 · Cited by 41 · cited 1×
“Vanhoof and colleaques illustratively describe patients’ difficulties to implement the numerous rules for health behavior after transplantation into their daily routine[50].”
BackgroundAdherence to immunosuppression in adult lung transplant recipients: Prevalence and risk factors
Bosma, O. H., Vermeulen, K. M., Verschuuren, E. A., Erasmus, M. E., & van der Bij, W. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.05.007 · Cited by 40 · cited 13×
“Most publications focus on adherence to immunosuppressants, assessed with electronic medication event monitoring systems (MEMS), self-reports, or surrogate parameters like therapeutic drug monitoring[9,10].”
BackgroundInfluentialMedication Nonadherence After Lung Transplantation in Adult Recipients
Castleberry, A. W., Bishawi, M., Worni, M., Erhunmwunsee, L., Speicher, P. J., Osho, A. A., Snyder, L. D., & Hartwig, M. G. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.06.067 · Cited by 39 · cited 2×
“6% of patients and was associated with shorter unadjusted survival[11].”
BackgroundFlippin, M. S., Canter, C. E., & Balzer, D. T. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00061-9 · Cited by 31
Developing a Digital Medicine System in Psychiatry: Ingestion Detection Rate and Latency Period
Profit, D., Rohatagi, S., Zhao, C., Hatch, A., Docherty, J. P., & Peters-Strickland, T. S. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m10643 · Cited by 24 · cited 1×
“Ingestible sensors combined with or embedded in tablets may accurately determine taking adherence[23,24].”
BackgroundDefrancq, C., Wilde, N. D., Raes, A. M., Biervliet, S. V., Velde, S. V., Winckel, M. V., Bruyne, R. D., & Prytula-Ebels, A. (2019) · Pediatric Transplantation · doi:10.1111/petr.13388 · Cited by 23
Drick, N., Seeliger, B., Fuge, J., Tudorache, I., Greer, M., Welte, T., Haverich, A., & Gottlieb, J. (2018) · Clinical Transplantation · doi:10.1111/ctr.13214 · Cited by 17 · cited 2×
“In our transplant center, LTx and kidney transplant patients judged their adherence as poorer than health care professionals’ estimates, with our adherence score being an independent predictor of self-reported non-adherence in LTx patients[8,27].”
BackgroundResultSelf-citationDesirability and feasibility of wireless electronic monitoring of medications in clinical trials
Robiner, W. N., Flaherty, N., Fossum, T. A., & Nevins, T. E. (2015) · Translational Behavioral Medicine · doi:10.1007/s13142-015-0316-1 · Cited by 16 · cited 1×
“Most publications focus on adherence to immunosuppressants, assessed with electronic medication event monitoring systems (MEMS), self-reports, or surrogate parameters like therapeutic drug monitoring[9,10].”
BackgroundAssessing Medication Adherence in Solid-Organ Transplant Recipients
Lower Mainland Pharmacy Services, V. G. H., Su, G. C.-W., Greanya, E. D., Partovi, N., Yoshida, E. M., Shapiro, R. J., & Levy, R. D. (2013) · Experimental and Clinical Transplantation · doi:10.6002/ect.2013.0060 · Cited by 15 · cited 1×
“Other groups used the discrepancy between immunosuppressant dosages and prescription refills or data from health insurances for the assessment of adherence[35,36].”
MethodRecipient risk factors and lung transplant outcomes
Vandervest, K. M., & Zamora, M. R. (2013) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32836519ec · Cited by 13 · cited 1×
“Long-term allograft survival is limited by the development of chronic lung allograft dysfunction (CLAD), malignancy, infections, and comorbidities[1,2].”
Background(2011) · PubMed · Cited by 10
“Patients don’t lie”; a view on adherence in asthma
Møldrup, C., Stein, J., & Søndergaard, B. (2010) · Pharmacy World & Science · doi:10.1007/s11096-010-9439-0 · Cited by 9
Cited by
Levy, L., Huszti, E., Tikkanen, J., Ghany, R., Klement, W., Ahmed, M., Husain, S., Fiset, P. O., Hwang, D., Keshavjee, S., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15561 · Cited by 51
Wessels-Bakker, M. J., van de Graaf, E. A., Erp, J. M. K., Heijerman, H. G. M., Cahn, W., & Schappin, R. (2021) · Journal of Clinical Nursing · doi:10.1111/jocn.15931 · Cited by 36
Evaluation of a Home Monitoring Application for Follow Up after Lung Transplantation—A Pilot Study
Wijbenga, N., Hoek, R. A. S., Mathot, B. J., Seghers, L., van Weezel, J. J., den Ouden, J., Wijsenbeek, M. S., Aerts, J. G. J. V., Hellemons, M. E., & Moor, C. C. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040240 · Cited by 12
“When these automated alerts are integrated in the application for lung transplant recipients, lung function decline can potentially be easily detected, and patients who normally hesitate to communicate about lung function declines can be treated in a timely manner [4,15,16].”
BackgroundAn E-Learning Program Improves Patients' Knowledge After Lung Transplantation
Guldager, T. B., Hyldgaard, C., Hilberg, O., & Bendstrup, E. M. (2020) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2020.0101 · Cited by 13
Reed, A. K., Mercier, O. M., Behr, J., Dave, K., Dellgren, G., Kotecha, S., Kukreja, J., Landry, C., Levvey, B. J., Lyster, H. S., et al. (2025) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.07.033 · Cited by 18
Metadata
- Authors
- Bertram, A., Fuge, J., Suhling, H., Tudorache, I., Haverich, A., Welte, T., & Gottlieb, J.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Bertram, Anna
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-12-17
- Volume
- 14
- Issue
- 12
- Pages
- e0226167
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6917262
- OpenAlex
- W2996507705
- Semantic Scholar
- 41200fa8e5e25d9ba1fae16a9d869f823272a3a9
- Cited by
- 34
- References
- 56
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 1 · 2023: 5 · 2022: 7 · 2021: 3 · 2020: 4 · 2019: 1
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (submittedVersion, cc-by)
- PubMed Central (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Keywords
- medication adherence, lung transplantation, allograft survival, chronic lung allograft dysfunction, patient survival, trough level monitoring, home spirometry, quality of life
- MeSH terms
- Adult, Child, Female, Humans, Male, Middle Aged, Patient Compliance, Quality of Life, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.